|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.325 SEK | -1.85% |
|
+16.23% | -27.20% |
| Jul. 16 | Flerie Concludes Mandatory Cash Offer for Nanologica | MT |
| Jul. 16 | Minimal Acceptance for Flerie's Mandatory Offer on Nanologica | FW |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Drug Delivery Technologies | ||||||||||
Chroma | 4.47M | 1.91M | 1.56M | 1.44M | - | |||||
Gross Profit | 1.52M | -2.48M | -973K | -3.28M | - | |||||
Operating Income | -10.49M | -19.42M | -23.66M | -44.03M | - | |||||
Unallocated Business Support | - | 642K | - | - | - | |||||
Gross Profit | -8K | -2K | - | -5K | - | |||||
Operating Income | -11.58M | -15.2M | -16.13M | -13.99M | - | |||||
Biological Products | ||||||||||
Drug Development - DD | 11.67M | 10.36M | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Gross Profit | 11.39M | 5.59M | -64K | -23K | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | 2.5M | -6.08M | -11.07M | -11.95M | - | |||||
Net Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
China | 3.32M | 1.31M | 699K | 654K | 8.43M | |||||
India | - | - | - | 188K | 5.92M | |||||
Total Assets | - | - | - | 32.57M | - | |||||
Rest of The World | 2.36M | 1.62M | 182K | 601K | 175K | |||||
USA | 410K | 103K | 276K | - | 21K | |||||
Turkey | - | - | 398K | - | - | |||||
Corporate | - | 642K | - | - | - | |||||
Sweden | 10.04M | 9.24M | - | - | - | |||||
Total Assets | - | - | - | 6.33M | - | |||||
Interest Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
- Stock Market
- Equities
- NICA Stock
- Financials Nanologica AB
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
